VRT Research Note — Backlog Meets the Conversion Test
Orders and backlog surged, but the July revenue shortfall leaves conversion as the central evidence test.
Orders and backlog surged, but the July revenue shortfall leaves conversion as the central evidence test.
Vertiv’s order surge and guidance raise strengthen the demand thesis, while backlog conversion remains the unresolved test.
Broad market participation supports the advance, while a contracting July payroll reading and a 4.66% ten-year yield temper the broader macro case.
BioVie’s subgroup signal does not resolve the missing registered endpoint or the scale of pending dilution.
BIVI offers a covered 6.75% yield and fixed-rate debt, while Caesars lease uncertainty keeps tenant concentration at the center of the thesis.
Broad participation has repaired the tape, but CPI arrives Wednesday with the 10-year at 4.66% and the VIX at 14.9, leaving little room for surprise.
VICI looks inexpensive on AFFO and yield, but Caesars lease talks and two-tenant concentration explain why the discount persists.
VICI offers a covered 6.75% yield and fixed-rate debt, while Caesars lease uncertainty keeps tenant concentration at the center of the thesis.
WULF’s HPC mix shifted sharply, but declining revenue, negative adjusted EBITDA and a rising share count keep financing quality central.
WULF’s HPC mix reached 71% of quarterly revenue, but negative adjusted EBITDA and a 17.9% quarterly increase in shares leave the cash bridge unresolved.